Astera Labs, Inc. (NASDAQ:ALAB – Get Free Report) COO Sanjay Gajendra sold 94,971 shares of the company’s stock in a transaction dated Tuesday, February 17th. The stock was sold at an average price of $123.81, for a total transaction of $11,758,359.51. Following the completion of the transaction, the chief operating officer owned 1,531,301 shares of the company’s stock, valued at approximately $189,590,376.81. This trade represents a 5.84% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link.
Astera Labs Stock Performance
Shares of ALAB traded down $0.96 during mid-day trading on Friday, reaching $131.66. 757,372 shares of the company’s stock traded hands, compared to its average volume of 5,598,292. The business’s 50-day moving average price is $160.78 and its 200-day moving average price is $174.12. The stock has a market capitalization of $22.24 billion, a P/E ratio of 108.01, a price-to-earnings-growth ratio of 2.55 and a beta of 1.50. Astera Labs, Inc. has a 12 month low of $47.13 and a 12 month high of $262.90.
Astera Labs (NASDAQ:ALAB – Get Free Report) last issued its quarterly earnings data on Tuesday, February 10th. The company reported $0.58 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.51 by $0.07. The business had revenue of $270.58 million during the quarter, compared to analyst estimates of $249.46 million. Astera Labs had a return on equity of 16.87% and a net margin of 25.70%.The business’s revenue for the quarter was up 91.8% compared to the same quarter last year. During the same period in the prior year, the company posted $0.37 EPS. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. Equities research analysts anticipate that Astera Labs, Inc. will post 0.34 EPS for the current year.
Institutional Inflows and Outflows
Analyst Ratings Changes
Several equities analysts have commented on the stock. Jefferies Financial Group reissued a “buy” rating on shares of Astera Labs in a research note on Wednesday, December 3rd. Barclays set a $165.00 price objective on shares of Astera Labs in a research note on Thursday, January 15th. BNP Paribas Exane assumed coverage on Astera Labs in a research report on Thursday, November 20th. They issued an “outperform” rating for the company. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Astera Labs in a research note on Wednesday, January 21st. Finally, Royal Bank Of Canada started coverage on Astera Labs in a research report on Wednesday, January 14th. They set an “outperform” rating and a $225.00 price target on the stock. Fourteen equities research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company’s stock. According to data from MarketBeat, Astera Labs presently has a consensus rating of “Moderate Buy” and a consensus target price of $192.89.
Get Our Latest Stock Report on ALAB
More Astera Labs News
Here are the key news stories impacting Astera Labs this week:
- Positive Sentiment: Analyst note: Zacks highlights rising AI connectivity demand and Astera’s expansion of its NVLink and Scorpio product lines, framing a multiyear market opportunity that management is targeting (potential upside to revenue growth). ALAB Rides on Strong Connectivity Demand
- Positive Sentiment: Fundamentals & liquidity: A Seeking Alpha piece notes revenue more than doubled YoY, very strong free cash flow margins (above 30%), and a cash position of roughly $1.19B with zero debt — giving Astera financial flexibility to invest or weather headwinds. The Great Astera Labs Reset
- Neutral Sentiment: Short-interest data is effectively immaterial/odd (reported as zero shares and a 0.0 days ratio), so there’s no clear short-pressure signal to explain intraday moves. This looks like a non-factor for current trading dynamics. Short Interest Report
- Negative Sentiment: CEO sale: CEO Jitendra Mohan sold 94,971 shares at ~$123.81 (≈$11.76M), trimming his holding by ~6.14% — a large, pre-scheduled or open-market sale that can be viewed negatively by the market when combined with other insider activity. CEO Form 4
- Negative Sentiment: COO sale: COO Sanjay Gajendra sold 94,971 shares at ~$123.81 (≈$11.76M), reducing his position by ~5.84% — another large insider disposition on the same date that amplifies investor concern. COO Form 4
- Negative Sentiment: CFO sale: CFO Michael Truett Tate sold 12,001 shares at ~$123.81 (≈$1.49M), cutting his stake by ~5.88% — another senior officer sale the same day. CFO Form 4
- Negative Sentiment: General Counsel sale: GC Philip Mazzara sold 4,849 shares at ~$123.80 (≈$600k), a smaller but concurrent insider reduction. Multiple senior officers selling on the same day increases perceived signal of near‑term liquidity taking or diversification by insiders. GC Form 4
About Astera Labs
Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.
The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.
Recommended Stories
- Five stocks we like better than Astera Labs
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- From Quiet Compounder to 2026 Breakout? BSEM
- Unlocked: Elon Musk’s Next Big IPO
- My Epstein Story
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.
